News

Published on 10 Nov 2021 on WFMZ Eastern Pennsylvania and Western New Jersey

RNA Analysis/ Transcriptomics Global Market Report 2021


Article preview image

DUBLIN, Nov. 10, 2021 /PRNewswire/ -- Market to grow and reach $8.62 Billion in 2025 according to...

NYSE.BIO price evolution
NYSE.BIO-B price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and...

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In t...

Insider Monkey · via Yahoo Finance 19 Aug 2024

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its...

The first-quarter results for Bio-Rad Laboratories, Inc. (NYSE:BIO) were released last week, maki...

Simply Wall St. via Yahoo Finance 10 May 2024

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down

Bio-Rad Laboratories, Inc. BIO posted first-quarter 2024 adjusted earnings per share (EPS) of $2....

Zacks via Yahoo Finance 8 May 2024

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Labora...

Insider Monkey via Yahoo Finance 8 May 2024

Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market Challenges

Revenue: Reported $610.8 million, a decrease of 9.8% year-over-year, falling short of estimates o...

GuruFocus.com via Yahoo Finance 7 May 2024

New Strong Sell Stocks for April 19th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ATN International, Inc...

Zacks via Yahoo Finance 19 Apr 2024

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?...

Ninety-six percent, or 480 out of the 500 companies comprising the S&P 500 index, are trading at ...

Benzinga 19 Apr 2024

Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?

Bio-Rad Laboratories, Inc. (BIO Quick QuoteBIO - Free Report) is expected to release first-quarte...

Zacks 18 Apr 2024

Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week,...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term Bi...

Simply Wall St. via Yahoo Finance 17 Apr 2024

Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition

Bio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma sp...

Zacks via Yahoo Finance 16 Apr 2024